Health Catalyst CFO Alger Jason forfeited 17,973 shares at $1.70 per share on September 1, 2026. The transaction matters to investors because it leaves the named executive with 704,867 Health Catalyst shares, defining his reported ownership after the share forfeiture.
Key Highlights
- The share transaction occurred on September 1, 2026.
- Alger Jason held 704,867 Health Catalyst shares after the transaction.
- Alger Jason is Health Catalyst’s Chief Financial Officer.
Health Catalyst, Inc. (NASDAQ: HCAT) recorded a share forfeiture involving Chief Financial Officer Alger Jason. The transaction covered 17,973 shares at $1.70 per share, while his post-transaction ownership stood at 704,867 shares.
Health Catalyst CFO’s Post-Transaction Holdings
Alger Jason serves as Health Catalyst’s Chief Financial Officer. The share transaction took place on September 1, 2026, and involved Health Catalyst shares forfeited at the stated per-share amount. Jason’s ownership following the transaction was 704,867 shares. The filing identifies Alger Jason as the individual involved in the transaction and identifies him as chief financial officer. Health Catalyst’s reported figures pair the forfeited share count with a $1.70 per-share value and a post-transaction holding of 704,867 shares.
FAQs
Q: How many Health Catalyst shares did Alger Jason forfeit?
A: Health Catalyst CFO Alger Jason forfeited 17,973 shares in the transaction. The shares were recorded at $1.70 per share. The Form 4 filing reports this forfeiture.
Q: How many Health Catalyst shares does Alger Jason own after the transaction?
A: Alger Jason owned 704,867 Health Catalyst shares following the transaction. He is the company’s Chief Financial Officer. The filing reports this post-transaction ownership figure.
Q: When did the Health Catalyst share forfeiture occur?
A: The Health Catalyst share forfeiture occurred on September 1, 2026. The transaction involved CFO Alger Jason and 17,973 shares. The filing identifies the transaction date.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.